Pulmonary immunity to Pseudomonas aeruginosa.
Pseudomonas aeruginosa, an opportunistic bacterial pathogen, is a major course of morbidity and mortality in subjects with compromised respiratory function despite the significant advances in therapeutic practices. The bacteria produces an armoury of products which modify its infective niche to ensure bacterial survival. The role of antibody in protection against pulmonary infection remains poorly defined. Protection appears to be associated with opsonizing antibody whilst some other antibody responses may be deleterious and promote further lung damage. Cell mediated responses are clearly important in protection against infection. This review proposes a vaccine strategy aimed at enhancing specific T cell responses in the lung which, though T cell-derived cytokines, drive the recruitment of neutrophils to the lung and the subsequent activation of these cells results in the clearance of bacteria from the lung.
Cripps
A W
AW
Faculty of Applied Science, University of Canberra, Australia.
Dunkley
M L
ML
Clancy
R L
RL
Kyd
J
J
D000917:Antibody Formation; D006801:Humans; D007111:Immunity, Cellular; D018836:Inflammation Mediators / Q000276:immunology; D008168:Lung / Q000276:immunology* / Q000382:microbiology; D018448:Models, Immunological; D018410:Pneumonia, Bacterial / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D011552:Pseudomonas Infections / Q000276:immunology*; D014611:Vaccination
D018836:Inflammation Mediators